Safety,tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine,followed by sequential PPSV23 vaccination in healthy adults aged?≥50?years: A randomized phase III trial (PNEU-PATH) |
| |
摘 要: |
|
收稿时间: | 20 May 2021 |
本文献已被 ScienceDirect 等数据库收录! |
|